Could Tim Russert Be A Victim Of Big Pharma/FDA Scam
Medicare: Thousands of Medicare Providers Abuse the Federal Tax System
F.D.A. Issues Strictest Warning on Diabetes Drugs
As America ages, the GREED factor related to Health Care grows exponentially. 
Services provided are watered down and cost is inflated to squeeze every penny out of the US Taxpayer. 
Health Care is no longer the realm of humanitarian motives. Health Care is BIG BUSINESS with roots in Pharmaceuticals and Hospital Corporations. The argument for and against the medical industry under government control has its benefits and drawbacks. The most glaring Benefit is oversight (Drawback: if America can ever get that concept to work), for service the medical system provides. This is not the “Socialized Medicine” that corrupt Medical Businesses would like you to believe. This is a cap on the outrageous price fixing they have enjoyed for too long. There are too many examples to cite for price fixing … just ask yourself why patients have traveled to other countries to get affordable treatment. The Medical Industry has lost its way. The US Government has victimized taxpayers by lining their pockets with kickbacks from their “Golden Goose”. The US Taxpayer has funded too much fraud and waste in general. But, when it comes to basic health care, the US Taxpayer is out of luck. Corrupt business has marketed the fear of “Socialized Medicine” so well, that self-serving semantics have re-defined the whole concept of medical oversight.
Western Medicine Fails Tim Russert A Glaring Omission of the Facts
The most glaring omitted information from Russert’s doctor is telling us what diabetes medication he was taking. I am willing to bet that he was taking Avandia, the drug the FDA should have pulled off the market because it causes a whopping 43% increased risk of a sudden heart attack, information the FDA actively sought to sequester during that drug’s approval process. Why do I think that? Because in the scant health data his doctor is giving out he has stated that Russert had high triglycerides and low HDL cholesterol – the exact metabolic profile that Avandia is supposed to treat. When a treatment has death as a common side effect it can hardly be considered a treatment.
Could it be that Russert is a casualty of one of the great Big Pharma/FDA scams currently going on? How ironic, since all news programs are sponsored by this industry’s ads and the media fought tooth and claw in the past year to ensure that dangerous drug ads could continue to run non-stop during all news programs – exposing millions of Americans to drug-induced injury (while they got their billions in ad revenues). I am stunned that no reporter interviewing his doctor seems to be able to ask such an obvious question.
Perverse Corruption as Doctors are Paid to Sell Drugs
FDA Collaboration with Big Pharma Raises Eyebrows
The Andrew von Eschenbach FDA era is upon us. 
The Avandia scandal is the tip of the iceberg. Is anyone ready? The words “illicit financial collusion” have been replaced by the politically correct term, “collaboration.” On May 30, in defense of his cozy relationship with Big Pharma and Big Biotech von Eschenbach told reporters, “This is a collaboration, but it’s not just a collaboration with drug companies, it’s a collaboration with academia and with other agencies.” And he forgot to include that it is also a collaboration with various Senators, such as Senator Bennett (R-UT) and Senator Hatch (R-UT), as can be seen by the highly lucrative Critical Path Initiative program for cardiovascular disease research at the University of Utah.,
Avandia Scandal: Leading Diabetes Doc Warned FDA About Risks In 2000
For now, Avandia is the new Vioxx.
The New York Times poked around the FDA web site and unearthed a letter written in 2000 by John Buse, chief of endocrinology at the University of North Carolina in Chapel Hill, who is about to become the president of the American Diabetes Association.
He cited “a worrisome trend in cardiovascular deaths and severe adverse events†among patients using the drug. He also accused Glaxo of “pervasive and systemic” attempts to minimize Avandia’s risks and overstate its benefits.
What else was found? A warning letter issued by the FDA to Glaxo in 2001, chastising the drugmaker for distributing materials at an endocrinolgoy convention that didn’t carry warnings on the Avandia label, which were ordred by the FDA to highlight heart and liver risks.
Buse wrote his letter in response to an FDA citizen’s petition filed by Public Citizen’s Sid Wolfe, who asked the agency to place warning labels on Rezulin, Avandia and Actos.
Referring to Avandia by its generic name, rosiglitazone, and to Rezulin as troglitazone, Dr. Buse wrote in the letter, “I do not believe that rosiglitazone will be proven safer than troglitazone in clinical use under current labeling of the two products.†He added: “In fact, rosiglitazone may be associated with less beneficial cardiac effects or even adverse cardiac outcomes.
Last Year: U.S SENATORS ALLEGE FDA COMPLICITY OVER AVANDIA SCANDAL.
Nationwide, there are about 2500 pharmaceutical facilities.
